Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue

Phase 2 Unknown 36 enrolled Istituto Clinico Humanitas

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A phase 2, randomized, placebo controlled trial evaluating the effects of n intravenous iron supplementation on chronic fatigue in IBD patients with controlled disease.

Timeline

Start: 2014-10
Primary completion: 2016-05
Completion: 2016-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ferric carboxymaltose	Other / unclassified	200 mg	Intravenous

Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue

Summary

Timeline

Drugs

Indications